Literature DB >> 19560232

Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?

Roberta Frigerio1, Hiroshige Fujishiro, Tae-Beom Ahn, Keith A Josephs, Demetrius M Maraganore, Anthony DelleDonne, Joseph E Parisi, Kevin J Klos, Bradley F Boeve, Dennis W Dickson, J Eric Ahlskog.   

Abstract

Lewy pathology occurs in 8-17% of neurologically normal people age >60, termed incidental Lewy body disease (iLBD). It is often assumed to represent preclinical Parkinson disease (PD). However, some iLBD cases have diffuse pathology inconsistent with preclinical PD. We analyzed iLBD cases (α-synuclein immunohistochemistry) using the Braak PD staging scheme and determined if some had a neuropathological pattern suggestive of preclinical dementia with Lewy bodies (DLB). Of the 235 brains examined, 34 had iLBD (14.5%) and all but one could be assigned a Braak PD stage. The distribution of α-synuclein pathology in the 33 cases fell into three patterns: (1) diffuse cortical and subcortical α-synuclein pathology; (2) no cortical α-synuclein pathology, but a caudal-to-rostral ascending pattern, primarily involving brainstem; and (3) intermediate between these two categories. Also, 6/33 cases failed to follow the pattern of contiguous spread proposed by Braak. These findings suggest dichotomy in the distribution of iLBD: some cases fit the Braak ascending scheme, conceptually consistent with preclinical PD, whereas others displayed prominent cortical involvement that might represent preclinical DLB.
Copyright © 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19560232      PMCID: PMC3366193          DOI: 10.1016/j.neurobiolaging.2009.05.019

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  42 in total

1.  Cell death or synaptic loss in Alzheimer disease.

Authors:  R D Terry
Journal:  J Neuropathol Exp Neurol       Date:  2000-12       Impact factor: 3.685

2.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease.

Authors:  H I Hurtig; J Q Trojanowski; J Galvin; D Ewbank; M L Schmidt; V M Lee; C M Clark; G Glosser; M B Stern; S M Gollomp; S E Arnold
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

3.  Risk tables for parkinsonism and Parkinson's disease.

Authors:  Alexis Elbaz; James H Bower; Demetrius M Maraganore; Shannon K McDonnell; Brett J Peterson; J Eric Ahlskog; Daniel J Schaid; Walter A Rocca
Journal:  J Clin Epidemiol       Date:  2002-01       Impact factor: 6.437

4.  Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response.

Authors:  Hulya Apaydin; J Eric Ahlskog; Joseph E Parisi; Bradley F Boeve; Dennis W Dickson
Journal:  Arch Neurol       Date:  2002-01

5.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

6.  Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry.

Authors:  R L Hamilton
Journal:  Brain Pathol       Date:  2000-07       Impact factor: 6.508

7.  Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p.

Authors:  K Gwinn-Hardy; N D Mehta; M Farrer; D Maraganore; M Muenter; S H Yen; J Hardy; D W Dickson
Journal:  Acta Neuropathol       Date:  2000-06       Impact factor: 17.088

8.  Accumulation of phosphorylated alpha-synuclein in aging human brain.

Authors:  Yuko Saito; Akiko Kawashima; Nyoka N Ruberu; Hideo Fujiwara; Shunichi Koyama; Motoji Sawabe; Tomio Arai; Hiroshi Nagura; Hiroshi Yamanouchi; Masato Hasegawa; Takeshi Iwatsubo; Shigeo Murayama
Journal:  J Neuropathol Exp Neurol       Date:  2003-06       Impact factor: 3.685

9.  Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.

Authors:  Kurt A Jellinger
Journal:  Acta Neuropathol       Date:  2003-07-05       Impact factor: 17.088

Review 10.  Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?

Authors:  Dag Aarsland; C G Ballard; Glenda Halliday
Journal:  J Geriatr Psychiatry Neurol       Date:  2004-09       Impact factor: 2.680

View more
  48 in total

1.  Essential tremor and Parkinson's disease: lack of a link.

Authors:  Charles H Adler; Holly A Shill; Thomas G Beach
Journal:  Mov Disord       Date:  2011-01-31       Impact factor: 10.338

Review 2.  Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease.

Authors:  Bradley F Boeve
Journal:  Lancet Neurol       Date:  2013-04-09       Impact factor: 44.182

Review 3.  Metals in Alzheimer's and Parkinson's Disease: Relevance to Dementia with Lewy Bodies.

Authors:  Erin J McAllum; David I Finkelstein
Journal:  J Mol Neurosci       Date:  2016-08-08       Impact factor: 3.444

4.  Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations.

Authors:  Sandra A Jacobson; Trisha Morshed; Brittany N Dugger; Thomas G Beach; Joseph G Hentz; Charles H Adler; Holly A Shill; Marwan N Sabbagh; Christine M Belden; Lucia I Sue; John N Caviness; Chengcheng Hu
Journal:  Parkinsonism Relat Disord       Date:  2014-06-28       Impact factor: 4.891

Review 5.  The spectrum of cognitive impairment in Lewy body diseases.

Authors:  Jennifer G Goldman; Caroline Williams-Gray; Roger A Barker; John E Duda; James E Galvin
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

Review 6.  Is Braak staging valid for all types of Parkinson's disease?

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2018-06-25       Impact factor: 3.575

Review 7.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

Review 8.  Innate and adaptive immune responses in Parkinson's disease.

Authors:  Aubrey M Schonhoff; Gregory P Williams; Zachary D Wallen; David G Standaert; Ashley S Harms
Journal:  Prog Brain Res       Date:  2019-12-05       Impact factor: 2.453

Review 9.  Parkinson's disease and parkinsonism: neuropathology.

Authors:  Dennis W Dickson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

10.  Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study.

Authors:  Jennifer Molano; Bradley Boeve; Tanis Ferman; Glenn Smith; Joseph Parisi; Dennis Dickson; David Knopman; Neill Graff-Radford; Yonas Geda; John Lucas; Kejal Kantarci; Maria Shiung; Clifford Jack; Michael Silber; V Shane Pankratz; Ronald Petersen
Journal:  Brain       Date:  2009-11-04       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.